heat shock protein 27 inhibitor nucleoside derivatives (Centre National de la Recherche Scientifique/Wuhan University/INSERM)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameheat shock protein 27 inhibitor nucleoside derivatives (Centre National de la Recherche Scientifique/Wuhan University/INSERM)
Drug Alias NameHSP27 inhibitor nucleoside derivatives (CNRS/Wuhan University/INSERM)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionHeat shock protein beta-1 inhibitors
TargetsHeat shock protein beta-1
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFranceMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInserm TransfertCentre National De La Recherche Scientifique (Cnrs)Inserm +[4] 
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A